NCT06648551 (CONUT) is a clinical trial of CONUT in Inflammatory Bowel Disease 5, sponsored by Hospital General de Mexico.

Who is sponsoring NCT06648551?

NCT06648551 is sponsored by Hospital General de Mexico.

What drugs are being tested in NCT06648551?

Interventions in NCT06648551: CONUT.

What condition does NCT06648551 study?

NCT06648551 studies Inflammatory Bowel Disease 5.

Is NCT06648551 still recruiting?

NCT06648551 is currently recruiting now. Last updated 18 October 2024.

Last reviewed 2024-10-18 · How we verify

NCT06648551: CONUT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Performance of Controlling Nutritional Status as a Nutritional Screening Tool in Patients With Inflammatory Bowel Disease

Recruiting now Last updated 18 October 2024

What this trial tests

trial testing CONUT in Inflammatory Bowel Disease 5 in 60 participants. Currently enrolling.

Timeline

28 October 2023

Primary endpoint
1 July 2025

28 October 2027

Quick facts

Lead sponsor	Hospital General de Mexico
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	60
Start date	28 October 2023
Primary completion	1 July 2025
Estimated completion	28 October 2027
Sites	1 location across Mexico

Drugs / interventions tested

CONUT

Conditions studied

Inflammatory Bowel Disease 5 — all drugs for Inflammatory Bowel Disease 5 →

Sponsor

Hospital General de Mexico

Who can join

Adults 18 to 80, any sex, with Inflammatory Bowel Disease 5. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this observational study is to determine the diagnostic performance of CONUT as a nutritional screening tool in patients with Inflammatory Bowel Disease. The main questions to be answered are: What is the sensitivity and specificity of CONUT as a nutritional screening tool in patients with Inflammatory Bowel Disease? The participants will: Undergo body composition analysis and a medical history review to understand the characteristics of their current condition, apply the GLIM criteria, and conduct their nutritional assessment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hospital General de Mexico trials

Trials by the same sponsor.

NCT07258043 — Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia · recruiting
NCT06589973 — Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients · recruiting
NCT06284395 — Two Schemes Response in Multiple Myeloma · recruiting
NCT05951803 — Effectiveness of a Psychological Intervention on Mental Health and Sleep. · NA · unknown
NCT04716738 — Visceral Sensitivity in Women With BS and Sexual Dysfunction · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06648551 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital General de Mexico
Last refreshed: 18 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06648551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing